Total Payments
$497,484
2024 Payments
$11,558
Companies
88
Transactions
2,120
Medicare Patients
1,595
Medicare Billing
$211,594
Payment Breakdown by Category
Other$327,907 (65.9%)
Travel$89,827 (18.1%)
Food & Beverage$49,244 (9.9%)
Consulting$19,750 (4.0%)
Research$10,647 (2.1%)
Education$108.81 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $312,034 | 107 | 62.7% |
| Travel and Lodging | $89,827 | 280 | 18.1% |
| Food and Beverage | $49,244 | 1,705 | 9.9% |
| Consulting Fee | $19,750 | 9 | 4.0% |
| Honoraria | $15,807 | 8 | 3.2% |
| Unspecified | $10,647 | 5 | 2.1% |
| Education | $108.81 | 5 | 0.0% |
| Entertainment | $65.33 | 1 | 0.0% |
Payments by Type
General
$486,837
2,115 transactions
Research
$10,647
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $156,691 | 409 | $0 (2024) |
| Daiichi Sankyo Inc. | $112,239 | 169 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $97,389 | 242 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $26,035 | 46 | $0 (2024) |
| GRT US Holding, Inc. | $17,941 | 42 | $0 (2022) |
| Pernix Therapeutics Holdings, Inc. | $16,829 | 30 | $0 (2018) |
| Medtronic, Inc. | $15,094 | 39 | $0 (2024) |
| Nevro Corp. | $11,967 | 246 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,363 | 12 | $0 (2020) |
| Depomed, Inc. | $4,442 | 18 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,558 | 115 | SCILEX PHARMACEUTICALS INC. ($4,218) |
| 2023 | $22,341 | 176 | Medtronic, Inc. ($12,063) |
| 2022 | $28,557 | 223 | GRT US Holding, Inc. ($17,196) |
| 2021 | $22,779 | 249 | SCILEX PHARMACEUTICALS INC. ($14,577) |
| 2020 | $19,479 | 222 | Boston Scientific Corporation ($14,681) |
| 2019 | $44,896 | 299 | Boston Scientific Corporation ($22,491) |
| 2018 | $185,662 | 400 | BOSTON SCIENTIFIC CORPORATION ($96,716) |
| 2017 | $162,212 | 436 | Collegium Pharmaceutical, Inc. ($84,937) |
All Payment Transactions
2,120 individual payment records from CMS Open Payments — Page 1 of 85
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $2.18 | General |
| Category: Pain management | ||||||
| 12/31/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $1.79 | General |
| Category: Pain management | ||||||
| 12/31/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $1.40 | General |
| Category: Pain management | ||||||
| 12/11/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $4.66 | General |
| Category: Pain management | ||||||
| 12/10/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $837.00 | General |
| Category: Analgesic | ||||||
| 12/10/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.19 | General |
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $5.62 | General |
| Category: Pain management | ||||||
| 12/10/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $2.90 | General |
| Category: Pain management | ||||||
| 12/10/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $0.94 | General |
| Category: Pain management | ||||||
| 11/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $107.72 | General |
| 11/14/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/12/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/07/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $149.50 | General |
| Category: SPINAL HARDWARE | ||||||
| 10/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Analgesic | ||||||
| 10/29/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2024 | PROTEGA PHARMACEUTIALS INC | — | Honoraria | Cash or cash equivalent | $825.00 | General |
| 10/18/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/18/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/15/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $81.39 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/15/2024 | Boston Scientific Corporation | Infinion 16 (Device) | Food and Beverage | In-kind items and services | $46.47 | General |
| Category: Infinion_NMD | ||||||
| 10/15/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/09/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Pain management | ||||||
| 10/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $19.75 | General |
| Category: Pain management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PRO | Boston Scientific Corporation | $9,075 | 2 |
| PATIENT RETROSPECTIVE OUTCOMES STUDY | Boston Scientific Corporation | $1,236 | 2 |
| PATIENT RETROSPECTIVE OUTCOMES STUDY | BOSTON SCIENTIFIC CORPORATION | $335.70 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 315 | 506 | $215,129 | $35,907 |
| 2022 | 9 | 245 | 483 | $119,627 | $30,231 |
| 2021 | 13 | 480 | 1,285 | $192,710 | $76,659 |
| 2020 | 15 | 555 | 1,180 | $194,259 | $68,796 |
Total Patients
1,595
Total Services
3,454
Medicare Billing
$211,594
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 246 | $52,287 | $14,158 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 77 | $24,183 | $6,723 | 27.8% |
| 64555 | Insertion of peripheral nerve neurostimulator electrode through skin | Facility | 2023 | 11 | 22 | $77,467 | $3,718 | 4.8% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 19 | 19 | $11,328 | $3,311 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $10,524 | $2,152 | 20.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 30 | 32 | $4,980 | $1,723 | 34.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 12 | 14 | $11,541 | $1,405 | 12.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 17 | 19 | $13,588 | $1,338 | 9.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 12 | 14 | $5,794 | $797.72 | 13.8% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Facility | 2023 | 18 | 20 | $3,430 | $579.08 | 16.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 16 | 21 | $7.31 | $2.00 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 323 | $61,825 | $19,195 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 35 | $10,500 | $3,176 | 30.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 21 | 23 | $14,945 | $1,931 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $6,219 | $1,677 | 27.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 12 | 30 | $5,088 | $1,213 | 23.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 12 | 15 | $10,462 | $1,148 | 11.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 20 | 21 | $7,342 | $1,022 | 13.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $3,243 | $867.68 | 26.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 12 | $4.32 | $1.19 | 27.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 184 | 852 | $106,500 | $52,735 | 49.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 28 | 32 | $9,600 | $6,360 | 66.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 61 | $9,150 | $4,536 | 49.6% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2021 | 19 | 27 | $17,650 | $2,344 | 13.3% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 15 | 41 | $6,150 | $1,550 | 25.2% |
About Romanth Waghmarae
Romanth Waghmarae is a Anesthesiology healthcare provider based in Hamburg, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174530299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Romanth Waghmarae has received a total of $497,484 in payments from pharmaceutical and medical device companies, with $11,558 received in 2024. These payments were reported across 2,120 transactions from 88 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($312,034).
As a Medicare-enrolled provider, Waghmarae has provided services to 1,595 Medicare beneficiaries, totaling 3,454 services with total Medicare billing of $211,594. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Hamburg, NY
- Active Since 08/02/2006
- Last Updated 09/30/2025
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174530299
Products in Payments
- Xtampza ER (Drug) $95,802
- SPECTRA WAVEWRITER (Device) $69,876
- Morphabond ER (Drug) $59,796
- Movantik (Drug) $52,481
- PRECISION (Device) $31,003
- ZTLido (Drug) $25,805
- GENERAL PAIN MANAGEMENT (Device) $20,742
- Qutenza (Drug) $17,941
- ZOHYDRO ER (Drug) $16,829
- INTELLIS ADAPTIVESTIM (Device) $12,299
- Senza Spinal Cord Stimulation System (Device) $9,126
- GENERAL - PAIN MANAGEMENT (Device) $8,814
- THERAPIES (Device) $8,674
- SPECTRA (Device) $7,934
- MOVANTIK (Drug) $5,363
- Nucynta (Drug) $4,442
- GENERAL THERAPIES (Device) $3,189
- EMBEDA (Drug) $2,830
- VANTA ADAPTIVESTIM (Device) $2,709
- Evoke (Device) $2,145
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.